Arthritis drugs tocilizumab and sarilumab reduce Covid deaths: Study

WASHINGTON: Arthritis drugs tocilizumab and sarilumab reduce the risk of death and the need for ventilators among hospitalised Covid-19 patients, according to an analysis of nearly 11,000 patients published Tuesday.

© New Straits Times Press (M) Bhd